North America Male Infertility Market Forecast 2023-2032

The North America male infertility market is estimated to grow with a 4.17% CAGR between the forecast years 2023 and 2032. Presence of major market players, development of advanced devices, investments in R&D, ongoing approvals, the introduction of advanced diagnostics, increased awareness, and rising adoption of assisted reproductive technologies

MARKET INSIGHTS

The North America male infertility market growth analysis covers the evaluation of the United States and Canada. Multiple factors drive the male infertility market in Canada. Firstly, there has been a continuous decline in fertility rates in the country, indicating a growing need for infertility treatments. The rise in male infertility cases is another significant driver, with males accounting for up to 50% of cases in Canada. This highlights the demand for male-focused infertility solutions.

Additionally, the increasing incidence of cancer cases in Canada contributes to the growth of the male infertility market. Cancer treatments such as chemotherapy and radiation therapy can adversely affect male fertility, necessitating infertility treatments. Also, unhealthy lifestyles contribute to male infertility, including smoking, obesity, alcohol consumption, and sedentary lifestyles. The growing burden of these factors among the male population creates a greater demand for infertility treatments.

Overall, the combination of declining fertility rates, increasing male infertility cases, the rise in cancer incidence, strategic developments by market players, and unhealthy lifestyle factors are key drivers propelling the growth of the male infertility market in Canada.

COMPETITIVE INSIGHTS

Major market players include: Laboratory Corporation of America Holdings, AdvaCare Pharma, Aytu BioPharma, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51580

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
- 2.5.2. PREVALENCE OF DIABETES AND CANCER

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGING INFERTILITY INCIDENCES
- 3.1.2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH TREATMENT COSTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TEST TYPE

5.1. DNA FRAGMENTATION TECHNIQUE
5.2. OXIDATIVE STRESS ANALYSIS
5.3. MICROSCOPIC EXAMINATION
5.4. SPERM AGGLUTINATION
5.5. COMPUTER-ASSISTED SEMEN ANALYSIS
5.6. SPERM PENETRATION ASSAY
5.7. OTHER TEST TYPES

6. MARKET BY TREATMENT

6.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
6.2. MEDICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. NORTH AMERICA
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. NORTH AMERICA MALE INFERTILITY MARKET DRIVERS
- 7.1.3. NORTH AMERICA MALE INFERTILITY MARKET CHALLENGES
- 7.1.4. KEY PLAYERS IN NORTH AMERICA MALE INFERTILITY MARKET
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. UNITED STATES
  - 7.1.5.1.1. UNITED STATES MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.2. CANADA
  - 7.1.5.2.1. CANADA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS
8.2. COMPANY PROFILES
- 8.2.1. ADVACARE PHARMA USA
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. ANDROLOGY SOLUTIONS
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
- 8.2.3. AYTU BIOPHARMA
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
  - 8.2.3.3. STRENGTHS & CHALLENGES
- 8.2.4. BAYER GROUP
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. CAERUS BIOTECH
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
- 8.2.6. CINNAGEN CO
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
  - 8.2.6.3. STRENGTHS & CHALLENGES
- 8.2.7. EMD SERONO INC (MERCK SERONO)
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
  - 8.2.7.3. STRENGTHS & CHALLENGES
- 8.2.8. ENDO INTERNATIONAL PLC
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. HALOTECH DNA
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
- 8.2.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SANOFI
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SCSA DIAGNOSTICS
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. THERAMEX
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
- 8.2.14. VITROLIFE
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST
  - 8.2.15.3. STRENGTHS & CHALLENGES

Product Code: 51580

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MALE INFERTILITY
TABLE 2: NORTH AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: KEY PLAYERS OPERATING IN NORTH AMERICA MALE INFERTILITY MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: PORTER'S FIVE FORCES ANALYSIS
FIGURE 2: GROWTH PROSPECT MAPPING
FIGURE 3: MARKET MATURITY ANALYSIS
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: NORTH AMERICA MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022
FIGURE 6: NORTH AMERICA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 7: NORTH AMERICA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022
FIGURE 15: NORTH AMERICA MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 18: UNITED STATES MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: CANADA MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)